Kadmon Holdings Inc (KDMN) Major Shareholder Sells $1,809,906.93 in Stock

Kadmon Holdings Inc (NASDAQ:KDMN) major shareholder Goldentree Asset Management Lp sold 515,643 shares of the company’s stock in a transaction on Monday, June 26th. The stock was sold at an average price of $3.51, for a total transaction of $1,809,906.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Goldentree Asset Management Lp also recently made the following trade(s):

  • On Tuesday, July 11th, Goldentree Asset Management Lp sold 34,462 shares of Kadmon Holdings stock. The stock was sold at an average price of $3.69, for a total transaction of $127,164.78.
  • On Thursday, June 29th, Goldentree Asset Management Lp sold 64,375 shares of Kadmon Holdings stock. The stock was sold at an average price of $4.04, for a total transaction of $260,075.00.
  • On Tuesday, June 27th, Goldentree Asset Management Lp sold 108,827 shares of Kadmon Holdings stock. The stock was sold at an average price of $3.69, for a total transaction of $401,571.63.
  • On Thursday, June 22nd, Goldentree Asset Management Lp sold 767,363 shares of Kadmon Holdings stock. The stock was sold at an average price of $3.50, for a total transaction of $2,685,770.50.

Shares of Kadmon Holdings Inc (NASDAQ KDMN) traded down 1.5733% on Monday, hitting $3.0906. 211,455 shares of the company traded hands. The firm’s market capitalization is $160.24 million. Kadmon Holdings Inc has a 1-year low of $2.25 and a 1-year high of $11.73. The firm’s 50-day moving average is $2.80 and its 200 day moving average is $3.58.

Kadmon Holdings (NASDAQ:KDMN) last announced its earnings results on Monday, May 15th. The company reported ($0.39) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.52) by $0.13. The firm had revenue of $5.60 million during the quarter, compared to the consensus estimate of $4.25 million. The company’s revenue was down 42.3% compared to the same quarter last year. On average, analysts anticipate that Kadmon Holdings Inc will post ($1.67) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Kadmon Holdings Inc (KDMN) Major Shareholder Sells $1,809,906.93 in Stock” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://sportsperspectives.com/2017/07/17/goldentree-asset-management-lp-sells-515643-shares-of-kadmon-holdings-inc-kdmn-stock-updated-updated.html.

A number of institutional investors have recently made changes to their positions in the company. Perceptive Advisors LLC increased its position in shares of Kadmon Holdings by 134.7% in the first quarter. Perceptive Advisors LLC now owns 5,185,847 shares of the company’s stock worth $18,772,000 after buying an additional 2,976,190 shares in the last quarter. KCG Holdings Inc. purchased a new position in shares of Kadmon Holdings during the first quarter worth approximately $124,000. Renaissance Technologies LLC purchased a new position in shares of Kadmon Holdings during the first quarter worth approximately $158,000. AE Wealth Management LLC purchased a new position in shares of Kadmon Holdings during the first quarter worth approximately $391,000. Finally, JPMorgan Chase & Co. increased its position in shares of Kadmon Holdings by 11,654.8% in the first quarter. JPMorgan Chase & Co. now owns 228,866 shares of the company’s stock worth $829,000 after buying an additional 226,919 shares in the last quarter.

Several research analysts have commented on KDMN shares. Zacks Investment Research upgraded shares of Kadmon Holdings from a “hold” rating to a “buy” rating and set a $3.75 price objective for the company in a report on Tuesday, March 28th. HC Wainwright reiterated a “buy” rating and issued a $25.00 price target on shares of Kadmon Holdings in a research note on Monday, June 26th. Piper Jaffray Companies reiterated a “buy” rating and issued a $7.00 price target on shares of Kadmon Holdings in a research note on Friday. Finally, Citigroup Inc. decreased their price target on shares of Kadmon Holdings from $6.00 to $4.00 and set a “neutral” rating for the company in a research note on Monday, March 27th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $9.93.

Kadmon Holdings Company Profile

Kadmon Holdings, Inc is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases.

Insider Buying and Selling by Quarter for Kadmon Holdings (NASDAQ:KDMN)

Receive News & Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply